Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 7/20 | 0.66 |
| ▸ | APP | P05067 | 2/20 | 0.66 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.63 |
| ▸ | HRH1 | P35367 | 1/20 | 0.63 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.63 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.56 |
| ▸ | LDHA | P00338 | 1/20 | 0.56 |
| ▸ | CNR1 | P21554 | 1/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.56 |
| ▸ | CNR2 | P34972 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.56 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.56 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.56 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.56 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 0.56 |
| ▸ | CTSK | P43235 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21426166 | 0.84 | PTPN1 (0.88) | PTPN1APPSLC6A2HRH1OPRM1 | |
| SCHEMBL29467209 | 0.84 | PTPN1 (0.88) | PTPN1APPSLC6A2HRH1OPRM1 | |
| SCHEMBL23987190 | 0.83 | APP (0.63) | PTPN1APPSLC6A2HRH1OPRM1 | |
| SCHEMBL25560683 | 0.81 | SLC6A2 (0.83) | PTPN1APPSLC6A2HRH1OPRM1 | |
| SCHEMBL13214114 | 0.80 | SLC6A2 (0.87) | PTPN1APPSLC6A2HRH1OPRM1 | |
| SCHEMBL23363576 | 0.80 | SLC6A2 (0.87) | PTPN1APPSLC6A2HRH1OPRM1 | |
| SCHEMBL26487390 | 0.80 | SLC6A2 (0.87) | PTPN1APPSLC6A2HRH1OPRM1 | |
| SCHEMBL30125514 | 0.79 | PTPN1 (1.00) | PTPN1APPSLC6A2HRH1OPRM1 | |
| Daurichromenic Acid SCHEMBL29424248 | 0.79 | PTPN1 (1.00) | PTPN1APPSLC6A2HRH1OPRM1 | |
| Daurichromenic Acid SCHEMBL11218399 | 0.79 | PTPN1 (1.00) | PTPN1APPSLC6A2HRH1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220362320-A1 | METHODS FOR PREPARING EXTRACTS FROM PLANTS AND FUNGI | CANNA STREAM SOLUTIONS LTD. (CA) | 2022-11-17 | — | — | US | claimed |
| US-20220273585-A1 | Composition comprising at least one natural or synthetic non-euphoric cannabinoid and its method of manufacture | TILMAN (BE) | 2022-09-01 | — | — | US | claimed |
| EP-4049654-A1 | COMPOSITION COMPRISING AT LEAST ONE NATURAL OR SYNTHETIC CANNABINOID WITHOUT EUPHORIC EFFECT AND MANUFACTURING METHOD THEREOF | Eleonor (BE) | 2022-08-31 | — | — | EP | claimed |
| US-20250000806-A1 | Dry Powdered Formulations | PINATA HOLDINGS INC. | 2025-01-02 | — | — | US | disclosed |
| US-20240358650-A1 | INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS | PINATA HOLDINGS INC. | 2024-10-31 | — | — | US | disclosed |
| US-20240358649-A1 | INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS | PINATA HOLDINGS INC. | 2024-10-31 | — | — | US | disclosed |
| US-20240299297-A1 | STABLE EMULSIONS AND METHODS | HEMP HUNTER LABS INC (US) | 2024-09-12 | — | — | US | disclosed |
| US-20240041782-A1 | Oral Capsule Cannabinoid Formulations | PINATA HOLDINGS INC. | 2024-02-08 | — | — | US | disclosed |
| EP-4284321-A1 | STABLE EMULSIONS AND METHODS | Hemp Hunter Labs Inc. (US) | 2023-12-06 | — | — | EP | disclosed |
| US-20230381206-A1 | DRINK CONTAINING A FROZEN CANNABIS PRODUCT AND METHOD OF MAKING | HOT ICE LLC (US) | 2023-11-30 | — | — | US | disclosed |
| WO-2023230475-A1 | DRINK CONTAINING A FROZEN CANNABIS PRODUCT AND METHOD OF MAKING | Hot Ice, LLC (US) | 2023-11-30 | — | — | WO | disclosed |
| US-20230293555-A1 | COMPOSITIONS COMPRISING CANNABIDIOL AND FLAVANONES | YUZU LV LLC | 2023-09-21 | — | — | US | disclosed |
| WO-2023006699-A1 | CELLS AND METHOD FOR PRODUCING ISOPRENOID MOLECULES WITH CANONICAL AND NON-CANONICAL STRUCTURES | Københavns Universitet (DK) | 2023-02-02 | — | — | WO | disclosed |
| US-20220362320-A1 | METHODS FOR PREPARING EXTRACTS FROM PLANTS AND FUNGI | CANNA STREAM SOLUTIONS LTD. (CA) | 2022-11-17 | — | — | US | disclosed |
| US-20220273585-A1 | Composition comprising at least one natural or synthetic non-euphoric cannabinoid and its method of manufacture | TILMAN (BE) | 2022-09-01 | — | — | US | disclosed |
| EP-4049654-A1 | COMPOSITION COMPRISING AT LEAST ONE NATURAL OR SYNTHETIC CANNABINOID WITHOUT EUPHORIC EFFECT AND MANUFACTURING METHOD THEREOF | Eleonor (BE) | 2022-08-31 | — | — | EP | disclosed |
| WO-2022165006-A1 | STABLE EMULSIONS AND METHODS | HEMP HUNTER LABS INC. (US) | 2022-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240041782-A1 | Oral Capsule Cannabinoid Formulations | CNR2, CNR1, FAAH | PTPN1 4318/4885APP 1601/4885SLC6A2 1372/4885 |
| US-20220273585-A1 | Composition comprising at least one natural or synthetic non-euphoric cannabinoid and its method of manufacture | CNR2, CNR1, FAAH | PTPN1 2037/4885APP 681/4885SLC6A2 231/4885 |
| US-20250000806-A1 | Dry Powdered Formulations | LIPA, ADCYAP1R1, PCSK9 | PTPN1 4023/4885APP 271/4885SLC6A2 2087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.